Physician

Asad Javed, M.D.

According to 2025 Medicare claims, Asad Javed, M.D. (NPI: 1427339928) practices medical oncology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is STATE UNIVERSITY OF IOWA (NPI: 1477554814; TIN: 426004813) and primary practice location at 52242-1009. Javed is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Javed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 136 traditional Medicare patients, billed 474 HCPCS/CPT codes, and received $31,173 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 311 prescription claims across 51 beneficiaries totaling $805,460 in drug costs, led by Braftovi (Encorafenib). 2019 DME data shows 36 claims. Open Payments data shows 8 records totaling $163,151. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $14,420 and ending at $31,173. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $338 and ending at $805,460. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	103	183	$14,420
2018	200	641	$47,507
2019	187	416	$29,448
2020	74	179	$17,379
2021	115	310	$27,415
2022	155	526	$42,582
2023	156	566	$52,485
2024	136	474	$31,173

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	12	$338
2017	24	66	$104,921
2018	77	340	$474,326
2019	56	325	$560,829
2020	N/R	11	$9,433
2021	N/R	N/R	N/R
2022	21	81	$324,631
2023	44	193	$225,225
2024	51	311	$805,460

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	36	$3,558
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	40	40	$123
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	35	71	$89
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	52	119	$64
99442	Telephone medical discussion with physician, 11-20 minutes	15	16	$48
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	70	187	$47

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Braftovi	Encorafenib	32	960	$372,525
Mektovi	Binimetinib	32	960	$278,561
Eliquis	Apixaban	18	635	$11,727
Enoxaparin Sodium	Enoxaparin Sodium	15	400	$3,765
Hydrocortisone	Hydrocortisone	38	1,304	$794

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$1,349	Immunocore Limited
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$161,802	Merck Sharp & Dohme LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Asad Javed, M.D.?

Tedicare shows public-source Medicare data for Asad Javed, M.D. (NPI 1427339928), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Asad Javed, M.D. have ACO affiliation data?

Asad Javed, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Asad Javed, M.D.?

Asad Javed, M.D. is linked to STATE UNIVERSITY OF IOWA (billing NPI 1477554814) in the available physician profile data.

Does Asad Javed, M.D. have Open Payments data?

Asad Javed, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.